Best Data Science and Machine Learning Platforms - Page 23

How Many Data Science and Machine Learning Platforms Products Does G2 Track?

Total Products under this Category: 1,649

Category Stats (Sep 2026)

  • Average Rating: 4.46/5 The average rating of products in this category, based on all submitted ratings
  • Top Trending Product: Anyscale (+4.14%) - Among all products in this category, Anyscale recorded the largest rating increase compared to last month

Last updated: September 01, 2026

How Does G2 Rank Data Science and Machine Learning Platforms Products?

Why You Can Trust G2's Software Rankings:

  • 30 Analysts and Data Experts
  • 14,400+ Authentic Reviews
  • 1,649+ Products
  • Unbiased Rankings

G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.

G2 Grid® for Data Science and Machine Learning Platforms

G2 Grid® for Data Science and Machine Learning Platforms plotting products by satisfaction and market presence

Highlighted products: Databricks, Gemini Enterprise Agent Platform, SAS Viya, Google Cloud AutoML, Snowflake, IBM watsonx.data, MATLAB, and Dataiku.

Underlying data: [Grid® JSON](https://www.g2.com/categories/data-science-and-machine-learning-platforms/grids.json?focus%5B%5D=databricks&focus%5B%5D=gemini-enterprise-agent-platform&focus%5B%5D=sas-sas-viya&focus%5B%5D=google-cloud-automl&focus%5B%5D=snowflake&focus%5B%5D=ibm-watsonx-data&focus%5B%5D=matlab&focus%5B%5D=dataiku)

BenevolentAI AI-enabled drug discovery.

BenevolentAI is a leading clinical-stage company that integrates artificial intelligence (AI) with scientific expertise to revolutionize drug discovery and development. By leveraging its proprietary Benevolent Platform™, the company uncovers novel biological insights, predicts new drug targets, and develops first-in-class or best-in-class therapeutics for complex diseases. This innovative approach aims to enhance the efficiency and success rates of bringing new medicines to patients. Key Features and Functionality: - AI-Driven Target Identification: Utilizes advanced AI tools to analyze vast datasets, identifying novel drug targets with higher precision. - Integrated Scientific Expertise: Combines AI capabilities with in-house scientific knowledge and wet-lab facilities to validate findings and accelerate drug development. - Collaborative Partnerships: Engages in strategic collaborations with pharmaceutical companies like AstraZeneca and Merck to co-develop innovative treatments. - Diverse Therapeutic Focus: Develops a broad pipeline addressing various complex diseases, including idiopathic pulmonary fibrosis, chronic kidney disease, systemic lupus erythematosus, and heart failure. Primary Value and Problem Solved: BenevolentAI addresses the challenges of traditional drug discovery, which often involve high costs, lengthy timelines, and low success rates. By integrating AI with scientific research, the company streamlines the identification of viable drug targets and accelerates the development process. This approach not only reduces the time and resources required to bring new therapies to market but also increases the likelihood of clinical success, ultimately delivering innovative medicines to patients more efficiently.

Who Is the Company Behind BenevolentAI AI-enabled drug discovery.?

  • Seller: BenevolentAI
  • Year Founded: 2013
  • HQ Location: London, GB
  • LinkedIn® Page: linkedin.com
    77 employees on LinkedIn®

Beyond Genomix SA

Beyond Genomix SA is a Swiss MedTech company specializing in the development of next-generation technologies for analyzing non-coding DNA, with a particular emphasis on reproductive health. Their proprietary platform integrates advanced genomics, telomere analysis, and artificial intelligence to provide deep, actionable insights into age-related diseases and infertility. By converting complex aging processes into high-resolution, clinically actionable data, Beyond Genomix aims to revolutionize diagnostics and therapeutics in these critical areas. Key Features and Functionality: - Genomics Pipeline: Delves into molecular patterns that lead to age-associated diseases by analyzing telomere and senescence pathways. - Telomere Analysis: Utilizes high-throughput technology to identify new patterns in age-related diseases through detailed telomere examination. - Senescence Biomarkers: Employs AI-powered analysis to discover and characterize biomarkers associated with cellular aging and related diseases. - Data Science Integration: Generates multi-omics data and applies machine learning algorithms to uncover novel patterns in age-associated diseases. Primary Value and Solutions: Beyond Genomix addresses the challenges of diagnosing idiopathic infertility and age-related diseases by providing personalized, data-driven insights. Their platform enables the delivery of tailored treatment recommendations, optimizing both time and cost efficiency for individuals experiencing infertility. Additionally, by analyzing aging hallmarks, the company supports the development of diagnostics and therapeutics for age-associated diseases, thereby enhancing patient care and advancing medical research in longevity and reproductive health.

Who Is the Company Behind Beyond Genomix SA?

Billow

Who Is the Company Behind Billow?

binate ai

Binate ai is an enterprise AI and machine learning platform delivering production-ready solutions. It integrates automation, analytics, and decision intelligence to optimize operations across industries. Key features include AI agent development for autonomous decision-making, generative AI for content automation, predictive modeling, and NLP-powered chatbots. Engagement models include project delivery, dedicated AI pods with cross-functional teams, and embedded talent for seamless integration. Operating on secure cloud architectures like AWS, Azure, and Google Cloud, Binate AI ensures compliance with GDPR, ISO 27001, and HIPAA standards. The platform addresses workflow automation, predictive analytics, conversational AI, computer vision, and cybersecurity, serving sectors like healthcare, fintech, retail, manufacturing, logistics, real estate, and education by transforming data into actionable insights.

Who Is the Company Behind binate ai?

  • Seller: Binate ai
  • HQ Location: 716 Congress Ave #200, Austin, TX 78701, USA
  • LinkedIn® Page: www.linkedin.com
    1 employees on LinkedIn®

Bindwell

Who Is the Company Behind Bindwell?

  • Seller: Bindwell
  • Year Founded: 2024
  • HQ Location: San Francisco, US
  • LinkedIn® Page: www.linkedin.com
    4 employees on LinkedIn®

BioAI Health

BioAI Health is a biotechnology company specializing in the development of advanced machine learning technologies to map the causal biology of diseases, create digital biomarkers, and identify novel drug targets. Their mission is to revolutionize precision medicine by accelerating clinical research and development through AI-powered solutions. Key Features and Functionality: - PredictX Platform: A cutting-edge multimodal AI platform capable of ingesting diverse data types, including digital pathology, multiomics, and real-world evidence, to generate novel insights. - In-Silico Phenotype Projection: Utilizes advanced AI methodologies to build predictive and prognostic models across a broad range of therapeutic areas. - Causal AI for Drug Discovery: Employs causal AI techniques to understand disease biology, identify causal dependencies, and discover new drug targets, thereby accelerating drug approval processes. - AI Biomarker Services: Offers rapid genomic profiling and identification of genetic mutations within histopathology images using novel AI testing, significantly reducing patient biomarker screening time from weeks to hours. - Data Sourcing Services: Provides access to digital and biospecimen samples through a clinical data network, facilitating comprehensive data analysis. Primary Value and Solutions: BioAI Health addresses critical challenges in precision medicine by enhancing the efficiency and success rates of clinical trials. Their AI-driven solutions enable faster, more cost-effective drug development by providing: - Accelerated Patient Screening: Reduces the time required for patient biomarker screening, allowing for quicker identification of suitable candidates for clinical studies. - Improved Drug Efficacy: Utilizes AI to develop digital biomarkers and predictive models that enhance the effectiveness of therapeutic interventions. - Comprehensive Data Analysis: Integrates multimodal data analysis, including spatial transcriptomics and computational pathology, to offer a holistic understanding of disease mechanisms. - Collaborative Partnerships: Works closely with pharmaceutical companies, clinical laboratories, and academic cancer centers to develop and deploy AI-based tests, ensuring compliance with regulatory standards and data security. By leveraging their expertise in AI and machine learning, BioAI Health aims to transform the landscape of precision medicine, ultimately improving patient care and quality of life.

Who Is the Company Behind BioAI Health?

BioAro

Who Is the Company Behind BioAro?

  • Seller: BioAro
  • Year Founded: 2021
  • HQ Location: Calgary, CA
  • LinkedIn® Page: www.linkedin.com
    47 employees on LinkedIn®

Biographica

Biographica is an AI-driven platform dedicated to accelerating the development of more productive, sustainable, nutritious, and climate-resilient crops. By integrating cutting-edge machine learning with comprehensive biological data, Biographica identifies and prioritizes high-value genetic targets for crop gene-editing. This approach addresses the critical challenge of determining which genes to edit and how, thereby streamlining the crop development process and significantly reducing the time and cost associated with bringing new traits to market. Key Features and Functionality: - Comprehensive Biological Context Integration: Biographica's models incorporate a wide range of biological data, including protein sequences and structures, regulatory DNA variations, interaction networks, transcriptomic dynamics, and current scientific literature. This multi-modal approach captures subtle dependencies that influence trait expression, ensuring that identified targets are both theoretically promising and practically relevant. - Integrated Platform: Combining wet lab and dry lab processes into a single, iterative discovery engine, Biographica utilizes proprietary datasets for model training and in planta validation. This integration accelerates the discovery cycle and enhances predictive power with each experiment. - Novel Edit Identification: The platform is designed to uncover a broad spectrum of possible genetic edits, from protein-coding variants to subtle changes in regulatory DNA. By expanding beyond conventional targets, Biographica opens the door to more precise, effective, and durable innovations in crop improvement. Primary Value and User Solutions: Biographica addresses the pressing global food security crisis by enabling the rapid development of crops that are more productive, sustainable, and resilient to climate change. Traditional methods of developing new crop traits can take over a decade and incur significant costs. Biographica's AI-driven platform reduces these timelines by up to five years and decreases R&D expenses by millions. By identifying the most promising genetic targets within weeks, Biographica empowers gene-editing and breeding programs to efficiently produce high-value crop varieties, ensuring a more secure and sustainable food future.

Who Is the Company Behind Biographica?

BioMap

Who Is the Company Behind BioMap?

Bion Analytics

Bion Analytics offers a comprehensive data automation platform designed to streamline financial reporting and business intelligence processes for small and medium-sized enterprises (SMEs). By integrating various data sources into a centralized system, Bion enables real-time access to clean, structured data, facilitating informed decision-making and operational efficiency. Key Features and Functionality: - Data Integration: Seamlessly connects with multiple data sources, including ERP and CRM systems, ensuring up-to-date and reliable data without manual intervention. - Data Transformation: Utilizes an intuitive workflow designer to cleanse, structure, and model raw data, preparing it for meaningful analysis and reporting. - Automated Reporting: Generates customized, interactive reports that provide real-time insights into key performance indicators (KPIs), eliminating the need for manual evaluations. - AI-Powered Insights: Features ALVA, an AI assistant that supports ad hoc analyses, detects patterns, and identifies risks and opportunities, enabling proactive business decisions. Primary Value and Solutions Provided: Bion Analytics addresses the challenges SMEs face with manual data processing and fragmented reporting systems by offering an integrated, automated solution. This platform reduces the time and errors associated with traditional reporting methods, providing finance teams with accurate, real-time insights. By automating data integration and reporting, Bion empowers businesses to make faster, data-driven decisions, enhancing overall productivity and competitiveness.

Who Is the Company Behind Bion Analytics?

Bionsight

Bionsight is a pioneering biotechnology company that integrates artificial intelligence (AI) with chemoproteomics to revolutionize the drug discovery process. By combining advanced computational methods with experimental validation, Bionsight accelerates the identification of therapeutic targets, reducing the timeline from years to mere months. Their mission is to bridge the gap between computational prediction and experimental validation, making drug development faster, more efficient, and precise. Key Features and Functionality: - Target Identification: Utilizes AI-driven algorithms to discover high-quality therapeutic targets with unprecedented precision and confidence. - Protein Interactions: Decodes complex protein-ligand interactions, unveiling novel mechanisms of action that are crucial for effective drug development. - Predictive Models: Employs machine learning algorithms to predict drug efficacy and optimize lead compounds, enhancing the success rate of potential therapeutics. - Safety Profiling: Conducts comprehensive toxicity assessments to minimize late-stage failures and expedite regulatory approval processes. Primary Value and Solutions Provided: Bionsight addresses the inefficiencies and prolonged timelines inherent in traditional drug discovery by offering an integrated platform that combines AI with chemoproteomics. This approach enables pharmaceutical companies and research institutions to: - Accelerate the drug discovery process, reducing development time from years to months. - Enhance the precision of target identification, leading to more effective and safer therapeutics. - Gain comprehensive insights into protein interactions and mechanisms of action, facilitating the development of drugs for previously "undruggable" targets. By leveraging Bionsight's innovative technologies, organizations can transform their therapeutic development pipelines, bringing life-saving treatments to market more efficiently.

Who Is the Company Behind Bionsight?

BioRaptor

A 10,000-character limit gives room for a more complete description, but I would keep it around 4,000–5,000 characters so it remains scannable. BioRaptor is a bioprocess intelligence platform that helps scientists, engineers and manufacturing teams turn fragmented process data into actionable, reusable process knowledge. Bioprocess data is typically distributed across bioreactors, analytical instruments, spreadsheets, batch records, laboratory systems and external partners. Before teams can investigate a process question, they often need to manually find, clean, align and contextualize this data. BioRaptor automates that work, creating a consistent data layer across runs, equipment, scales and sites. The platform supports bioprocess development, scale-up, technology transfer and manufacturing. It is used across biologics, cell and gene therapy, precision fermentation, industrial biotechnology and CDMO operations. UNIFY BIOPROCESS DATA BioRaptor collects and harmonizes online, at-line and offline data from sources including bioreactors, analytical instruments, Excel and CSV files, batch records and laboratory notebooks. Data generated at different sampling frequencies is automatically aligned, while naming conventions and units can be standardized across equipment and systems. This gives teams a consistent view of the entire process rather than separate views of sensor data, analytical results and process metadata. COMPARE RUNS AND EXPLAIN VARIABILITY Scientists and engineers can compare runs, campaigns or process groups without rebuilding analyses in spreadsheets. Process trajectories, offline measurements, operating conditions, materials and outcomes can be evaluated together. Users can select specific parameters to investigate a hypothesis or apply hypothesis-free analysis to identify the factors most strongly associated with an observed outcome. This helps teams understand why runs behaved differently, identify potential process drivers and focus investigations on the most relevant evidence. MONITOR ACTIVE PROCESSES BioRaptor provides a unified view of active runs across bioreactors and facilities. Machine-learning-based anomaly detection can identify deviations from expected process behavior while a run is still in progress. Configurable alerts allow teams to respond before a deviation becomes a larger process disruption. Monitoring can include both individual signals and multivariate process behavior, providing more context than fixed high and low alarm limits alone. BUILD PREDICTIVE MODELS AND SOFT SENSORS BioRaptor enables bioprocess teams to build predictive models without writing code. Available approaches range from interpretable statistical models to machine-learning methods such as XGBoost. Models can be used to investigate process drivers, predict outcomes or create soft sensors. Soft sensors use existing online process signals to continuously estimate measurements such as glucose, lactate, LDH or cell density that would otherwise require offline sampling or additional analytical hardware. AUTOMATE REPORTING AND KNOWLEDGE CAPTURE End-of-run reports can be generated automatically using configurable templates. Graphs, process events, measurements and analytical outputs can be brought together in a repeatable format. Instead of leaving the conclusions from each campaign in spreadsheets, presentations or individual scientists’ memories, BioRaptor creates a reusable process-knowledge layer. Findings from one run or development program can be more easily accessed and applied during subsequent development, scale-up, transfer or manufacturing activities. CONNECT DEVELOPMENT AND MANUFACTURING BioRaptor helps maintain process context as work moves between development stages, equipment, sites and external partners. Teams can compare performance across scales, connect upstream and downstream data, and preserve lineage between runs, materials, process conditions and outcomes. For organizations working with CDMOs, the platform can bring externally generated data into the same structure as internal development data. This supports faster review, more transparent collaboration and evidence-based technology transfer. WORK WITH EXISTING SYSTEMS BioRaptor is not a LIMS or an ELN. It complements these systems by making the process and analytical data they contain usable for bioprocess analysis. The platform can integrate with LIMS, ELN, SCADA, data historians, cloud services and third-party analytical tools. Data can be ingested through secure connected workflows or imported from Excel, CSV, batch records and other offline sources. KEY CAPABILITIES • Automated bioprocess data collection and contextualization • Harmonization across equipment, systems, units and naming conventions • Alignment of online, at-line and offline measurements • Cross-run, cross-campaign, cross-scale and cross-site analysis • Investigation of process variability and outcome drivers • Real-time monitoring of active bioprocess runs • Machine-learning-based anomaly detection • Configurable email and text alerts • Automated and customizable end-of-run reports • Interactive graphs and dashboards • Batch and run lineage across upstream and downstream operations • Predictive modeling without coding • Soft sensors for continuously estimated process measurements • Role-based access control, audit trails and encryption WHO USES BIORAPTOR BioRaptor is designed for process development scientists, bioprocess engineers, MSAT teams, manufacturing teams, data and digital leaders, and CMC organizations that need to learn from data generated across the bioprocess lifecycle. Typical applications include: • Comparing development runs and identifying drivers of performance • Investigating unexpected variability or process deviations • Monitoring multiple active bioreactors from one view • Supporting process characterization and scale-up • Preparing data and evidence for technology transfer • Connecting sponsor and CDMO process data • Creating predictive models and virtual sensors • Standardizing recurring process and campaign reports • Preserving process knowledge across teams and programs DEPLOYMENT AND SECURITY BioRaptor is cloud-based, with typical implementation taking approximately two to four weeks, including data integration, user training and ongoing support. The platform provides encryption, role-based access control, audit trails and secure cloud infrastructure. It is built around ALCOA+ data-integrity principles and designed to support 21 CFR Part 11 electronic records and signatures. Customer data remains the property of the customer. It is segregated between customers and is not used to train models for other customers. THE OUTCOME BioRaptor reduces the time between generating process data and learning from it. By replacing repeated data preparation with a consistent analytical environment, teams can investigate issues faster, make better-supported process decisions and carry knowledge forward across development and manufacturing. Every run becomes more than a dataset. It becomes evidence the organization can use.

Who Is the Company Behind BioRaptor?

Bijou Barry
BB
Researched and written by Bijou Barry
Updated April 22, 2026